Healthcare
Live Price
Offline$0.8752
-2.10% today
1Y Change
-29.23%
Window
Jun 30, 2025 → Jun 22, 2026
Coverage: 245 bars · Jun 30, 2025 → Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
PDS Biotechnology Corporation (PDSB) is a Healthcare stock with a market cap of $50.00M and listed on NASDAQ. The stock last traded around $0.88 and down 29.2% across the available one-year price window (Jun 30, 2025 → Jun 22, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +28.2%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +28.2%, free cash flow -79057.5% with operating margin 0.0% and ROIC -0.6%. Stock Foundry combines PDSB price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
PDSB is 49.71 pts behind over the shared 1Y window.
PDSB had 50.49 pts deeper max drawdown than SPY.
PDSB beat SPY in 1 of 2 calendar years shown and trailed in 1.
PDSB
-29.23%
Normalized return
SPY
+20.48%
S&P 500
Excess Return
-49.71 pts
Relative to SPY
PDSB Max Drawdown
-59.62%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for PDSB and SPY.
| Year | PDSB | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | +12.99% | +6.71% | +6.28 pts | PDSB |
| 2025 | -39.62% | +11.19% | -50.82 pts | SPY |
Unable to load analyst forecasts.
Timed out loading forecasts for PDSB
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.